Pharmafile Logo

Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026

June 18, 2026 | ASCO, Congress, Pharma, healthcare, oncology, webinar 

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

- PMLiVE

Join our team for an expert debrief from ASCO® 2026. With a front-row seat across multiple client engagements, we’ll share the scientific highlights, attendee perspectives and strategic lessons from one of oncology’s most important annual gatherings, while exploring what smarter, more measurable congress engagement looks like in practice.

What we’ll cover

  • Key scientific and strategic themes emerging from ASCO® 2026
  • Attendee perspectives and trends shaping oncology congress engagement
  • Lessons from real-world client engagements and launch environments
  • Smarter approaches to congress strategy, engagement and measurement
  • Opportunities to drive sharper strategic decision-making through congress insights

The experts shaping the conversation

  • Mark Jackson, Managing Director, Emota, an Inizio Engage company
  • Matt Hoelzle, Chief Medical Officer, Inizio Evoke
  • Simon Davenport, Global Head of Exhibitions and Environments, Emota, an Inizio Engage company
  • Nick Bellomo, Director of Technology and Engagement, Inizio Medical
  • Jo Ann Saitta, Global Head of Data Strategy, Analytics, and AI, Inizio Ignite
  • Lynsey Holbrook, Global Client Development Director, Emota, an Inizio Engage company
Watch the webcast here.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.

Webcast: Virtual Q&A session – The future of digital health

In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.

Research Partnership is on the rise

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

What does the future hold for Light-chain Amyloidosis?

Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape…

Webcast: Securing a future for telehealth with immersive market research insights

Research Partnership investigate the current landscape, the challenges to adoption and the future for telehealth.

MAKING THE FIRST YEAR MATTER

*Mind+Matter closes its first year of business celebrating more than £4 million of new business wins in the UK *The global agency launched in Jan 21 has also been awarded…

Breaking the silence: It’s time to talk about the menopause

Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change.

News:

Senior Analytics Specialist joins Research Partnership

ASHFIELD HEALTH LAUNCHES HEALTH INTELLIGENCE PLATFORM, GRAVITY.AI

Dynamic data-driven solution unlocks deeper insights and powers stronger omnichannel experiences.

Article:

All change – how untangling human behaviour can encourage better health